Ledger.Open graph →
SEC Form D · filed June 19, 2020

Can-Fite BioPharma Ltd

Offering
$8.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PETACH TIKVA, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Pnina Fishman · Petach Tikva, L3Exec · DirectorMotti Farbstein · Petach Tikva, L3ExecAbraham Sartani · Petach Tikva, L3DirectorIsrael Shamay · Petach Tikva, L3DirectorYaacov Goldman · Yokne'am Illit, L3DirectorGuy Regev · Petach Tikva, L3DirectorIlan Cohn · Petach Tikva, L3DirectorJanon Costly · Washington, Washington, D.C.DirectorRay G. Quintana · SANTA FE, NMDirectorTerry Ransford · Chicago, ILDirectorKevin J. Ritterman · Fargo, NDExecTacey R. Viegas · Madison, ALExec · DirectorBarbara M. Fisk · Madison, ALDirectorJames R. Hudson, Jr · Huntsville, ALDirectorStephen E. Memishian · Palm Beach Gardens, FLDirectorMichael J. Mcvean · Dallas, TXDirectorSteven Eisner · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗